Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

doi:10.1186/1471-2334-5-58

BMC Infectious Diseases

Volume 5

Viewing options:

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Torti C
Lapadula G
Casari S
Puoti M
Nelson M
Quiros-Roldan E
Bella D
Pastore G
Ladisa N
Minoli L
Sotgiu G
Mazzotta F
Caputo SL
Di Perri G
Filice G
Tinelli C
Carosi G

on PubMed

Torti C
Lapadula G
Casari S
Puoti M
Nelson M
Quiros-Roldan E
Bella D
Pastore G
Ladisa N
Minoli L
Sotgiu G
Mazzotta F
Caputo SL
Di Perri G
Filice G
Tinelli C
Carosi G
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Email this article to a friend

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Carlo Torti , Giuseppe Lapadula , Salvatore Casari , Massimo Puoti , Mark Nelson , Eugenia Quiros-Roldan , Daniele Bella , Giuseppe Pastore , Nicoletta Ladisa , Lorenzo Minoli , Giovanni Sotgiu , Francesco Mazzotta , Sergio Lo Caputo , Giovanni Di Perri , Gaetano Filice , Carmine Tinelli , Giampiero Carosi and the EPOKA-MASTER Study Group

BMC Infectious Diseases 2005, 5:58doi:10.1186/1471-2334-5-58

Your name*
Your email address*
Recipient's email address*	(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:	I thought the following article from BMC Infectious Diseases (http://www.biomedcentral.com/home) would be of interest to you.